Followers | 20 |
Posts | 1722 |
Boards Moderated | 0 |
Alias Born | 11/17/2009 |
Thursday, June 29, 2017 8:53:31 PM
Here's the last financial statement produced from nanologix:
It's obvious who is doing well and who isn't.
Would you like me to show you a business that actually earns income and pays management less than this? I'm invested in one right now :)
Read 144 a little more thoroughly. It's quite different than your understanding. In any event, rule 144 and whether he or anyone else has sold restricted shares has little to do with anything. You're asserting that you can't benefit from stock until it's been sold. That's a ridiculius wives tale. Like an insurance policy, stock certificates can be used to increase ones net worth and be used as collateral in purchasing power.
According to GAAP rules, when stock grants are categorized as "compensation", they can only be used for executive compensation. Not to pay off lawyers. Regardless if nanologix is a registered company or not, by law they still must meet GAAP accounting standards when releasing financials. All financials list these stock grants as compensation which means they were used solely for executives.
I've run out of posts for the day. Any further responses will be given tomorrow.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM